Navigation Links
Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
Date:1/17/2011

Ebersberg, Germany, January 17, 2011 Eurofins MWG Operon, international market leader and expert for DNA sequencing, has signed a 2-year contract to supply DNA sequencing services to the Research Councils UK Shared Services Ltd (RCUK SSC Ltd). The contract may be extended to 3 years, and builds on a 5-year relationship developed as a preferred supplier of synthetic DNA and RNA oligonucleotides to the Research Councils.

RCUK SSC Ltd has been set up by the seven Research Councils of the UK (RCUK) to provide centralised services to the Research Councils and their institutes in human resources (HR), finance, procurement, Information Technology, Information Systems and grants processing. The shared service approach reduces costs whilst raising operational efficiency for the Councils.

"We are pleased to have the opportunity to further develop our relationship with RCUK. This contract will allow us to demonstrate our competence and strength in genomic services beyond the provision of synthetic DNA and RNA oligonucleotides", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "The synergies across our service offerings allow us to optimize our client service, from ordering convenience, to streamlined processes, through to faster turnaround time."

Richard Fowles, Category Manager at RCUK SSC Ltd commented, "RCUK SSC Ltd is pleased to announce the selection of Eurofins as one of its preferred suppliers of DNA sequencing services. Eurofins is already a proven supplier of oligos and we believe this new contract will afford them opportunities to further enhance their already strong reputation."

Eurofins MWG Operon also provides best in class next generation sequencing services, siRNA and gene synthesis services and is committed to continually optimizing and improving processes and product quality to ensure that they deliver their products and services in the fastest and most convenient manner possible.


'/>"/>

Contact: Dr. Jutta Huber
juttahuber@eurofins.com
49-809-282-89930
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
2. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. Eurofins MWG Operon and Genomatix launch strategic alliance
5. Verizon Business to Provide Global IP for Eurofins Scientific
6. Reading the signs: Plants and animals found common ground in response to microbial threats
7. China PharmaHub Signs Distribution Agreement with Integrated Biometrics
8. Studying the metabolome of smokers, Lombardi researchers find early signs of damage
9. Speed installation of system to monitor vital signs of global ocean, scientists urge
10. SailPoint Signs International Reseller Agreement with BMC Software
11. Road signs and traffic signals on DNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/24/2016)... 2016 Cercacor today introduced Ember TM ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, ... Rate in approximately 30 seconds. Smaller than a smartphone, ... access to key data about their bodies to help ... Hemoglobin carries oxygen to muscles. When ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... Savannah River Remediation LLC group evaluated ... NT-MAX Lake & Pond Sludge and Muck ... conjunction with Hexa Armor/ Rhombo cover manufactured by ... Discharge Elimination System requirements. The Savannah ... of elevated pH levels, above 8.5, especially during ...
(Date:12/8/2016)... Dec. 8, 2016  Partnering to fuel ... Technology Partners of Southeastern Pennsylvania ... parent company of Independence Blue Cross; and Safeguard Scientifics ... intentions for a $6 million funding initiative over a ... Responding to a burgeoning economic vitality in ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology: